A new trading day began on Tuesday, with HCA Healthcare Inc (NYSE: HCA) stock price down -0.17% from the previous day of trading, before settling in for the closing price of $327.63. HCA’s price has ranged from $250.67 to $417.14 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 6.95% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 15.45%. With a float of $182.34 million, this company’s outstanding shares have now reached $254.52 million.
In an organization with 310000 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 50.04%, operating margin of 15.08%, and the pretax margin is 12.55%.
HCA Healthcare Inc (HCA) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Care Facilities Industry. The insider ownership of HCA Healthcare Inc is 28.01%, while institutional ownership is 64.09%. The most recent insider transaction that took place on Nov 14 ’24, was worth 527,677. In this transaction SVP & Chief Ethics Officer of this company sold 1,474 shares at a rate of $357.99, taking the stock ownership to the 9,454 shares. Before that another transaction happened on Nov 14 ’24, when Company’s SVP-Internal Audit Services sold 3,897 for $350.00, making the entire transaction worth $1,363,950. This insider now owns 52,702 shares in total.
HCA Healthcare Inc (HCA) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 15.45% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.00% during the next five years compared to 12.21% growth over the previous five years of trading.
HCA Healthcare Inc (NYSE: HCA) Trading Performance Indicators
Here are HCA Healthcare Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.00. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.19. Likewise, its price to free cash flow for the trailing twelve months is 14.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 22.28, a number that is poised to hit 6.14 in the next quarter and is forecasted to reach 24.59 in one year’s time.
Technical Analysis of HCA Healthcare Inc (HCA)
Let’s dig in a bit further. During the last 5-days, its volume was 0.94 million. That was inferior than the volume of 1.2 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 42.00%. Additionally, its Average True Range was 8.57.
During the past 100 days, HCA Healthcare Inc’s (HCA) raw stochastic average was set at 12.82%, which indicates a significant decrease from 18.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 13.60% in the past 14 days, which was lower than the 26.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $370.35, while its 200-day Moving Average is $346.96. However, in the short run, HCA Healthcare Inc’s stock first resistance to watch stands at $331.54. Second resistance stands at $336.01. The third major resistance level sits at $338.98. If the price goes on to break the first support level at $324.10, it is likely to go to the next support level at $321.13. The third support level lies at $316.66 if the price breaches the second support level.
HCA Healthcare Inc (NYSE: HCA) Key Stats
With a market capitalization of 82.85 billion, the company has a total of 253,297K Shares Outstanding. Currently, annual sales are 64,968 M while annual income is 5,242 M. The company’s previous quarter sales were 17,487 M while its latest quarter income was 1,270 M.
